Cue Biopharma stock price
NASDAQ:CUE · Nasdaq · Healthcare · sector #16$18.95+11.21%Oct 21 close
Loading chart…
Cue Biopharma's chart data is dated 2026-10-21. There is no active technical signal. There are 2 published signal records.
Cue Biopharma last closed at $18.95 (+11.21%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -0.7×. Its overall grade ranks 676 of 727 stocks in Healthcare.
About this company
Cue Biopharma last closed at $18.95 (+11.21%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 676/727
Valuation grade D
Related stocks
- Merck & CoCustomer
- Bristol Myers SquibbCompetitor
- Gilead SciencesCompetitor
About Cue Biopharma
- What technical signals does Cue Biopharma (CUE) have?
- Cue Biopharma current technical signals: no active technical signal.
- Is Cue Biopharma a cup-and-handle pattern?
- No. Cue Biopharma has no valid Cup signal right now.
- What published figures are available for Cue Biopharma?
- Market cap: $49.72M. Trailing 12 months PER: -0.7×. Latest quarter PBR: 52.02×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Cue Biopharma, or open the plan table on the main site.
Ask Q about Cue Biopharma.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy